The Prize

Eligibility

The award addresses researchers whose excellent work significantly contributes to research in the area of neurodegenerative diseases.

 

All researchers may apply if a significant part of the research described in the publication has been conducted in Switzerland. Swiss researchers may submit work carried out abroad.

 

Both works in basic research and clinical research may be submitted.

 

The publication must be either published or accepted for publication in a peer-reviewed scientific journal.

1/1
1/1

The prize is awarded to the main author or the research team, in line with the guidelines of their institution.

 

All co-authors and institutions contributing to the publication may be mentioned by name in the written or verbal appraisal of the awarded research work.

 

The awardee is requested to present their awarded research.

 

The foundation committee may exceptionally decide to award more than one research work for the prize.

 

In case no application qualifies for the prize, the prize may be cancelled or postponed to the following year.

Conditions

Call for application

Prize Franco Regli 2020/2021

 

Application deadline and information for the 2020/2021 Prize to come.

Awardees

Franco Regli Prize 2018/2019

2018/2019

 

1st Prize: Daniela Latorre and Ulf Kallweit, for the work:
Daniela Latorre, Ulf Kallweit, Eric Armentani, Mathilde Foglierini, Federico Mele, Antonino Cassotta, Sandra Jovic, David Jarrossay, Johannes Mathis, Francesco Zellini, Burkhard Becher, Antonio Lanzavecchia, Ramin Khatami, Mauro Manconi, Mehdi Tafti, Claudio l. Bassetti & Federica Sallusto. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature, October 2018, 562(7725): 63-68.

2nd Prize (ex aequo): Giovanni Di Liberto, for the work:

Giovanni Di Liberto, Stanislav Pantelyushin, Mario Kreutzfeldt, Nicolas Page, Stefano Musardo, Roland Coras, Karin Steinbach, Ilena Vincenti, Bogna Klimek, Thomas Lingner, Gabriela Salinas, Nathalie Lin-Marq,Ori Staszewski, Marta Joana Costa Jordaõ, Ingrid Wagner, Kristof Egervari, Matthias Mack, Camilla Bellone, Ingmar Blümcke, Marco Prinz, Daniel D. Pinschewer, and Doron Merkler. Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. Cell 175, 4 October 2018, 1–14.

2nd Prize (ex aequo): Magdalini Polymenidou, for the work:
Florent Laferrière, Zuzanna Maniecka, Manuela Pérez-Berlanga, Marian Hruska-Plochan, Larissa Gilhespy, Eva-Maria Hock, Ulrich Wagner, Tariq Afroz, Paul J. Boersema, Gery Barmettler, Sandrine C. Foti, Yasmine T. Asi, Adrian M. Isaacs, Ashraf Al-Amoudi, Amanda Lewis, Henning Stahlberg, John Ravits, Francesca De Giorgi, François Ichas, Erwan Bezard, Paola Picotti, Tammaryn Lashley and Magdalini Polymenidou. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nature Neuroscience, Vol. 22, January 2019, 65–77.
 

Former awardees

 

2016/2017

1st Prize: Dr. med Christian Barro, Clinique neurologique et policlinique, Département de médecine, bio-médecine et recherche clinique, Hôpital universitaire de Bâle et Université de Bâle, for the work:

Disanto G*, Barro C*, Benkert P*, Naegelin Y, Schädelin S, Giardiello A,  Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J,  et the Swiss Multiple Sclerosis Cohort Study Group. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol, 2017, 81(6): 857-870. *equal contribution

2nd Prize: Prof. Dr. med. Caroline Pot and Dr. med. Aurélie Clottu, Département des neurosciences cliniques, Service de neurologie, CHUV, Lausanne, for the work:

Clottu A, Mathias A, Sailer AW, Schluep M, Seebach JD, Du Pasquier R, Pot C. EBI2 expression and function: robust in memory lymphocytes and increased by natalizumab in multiple sclerosis. Cell Rep. 3 January 2017,18(1): 213-224. 

2013

Dr. Tiziana Sonati, Dr. Regina M. Reimann, Prof. Dr. Adriano Aguzzi, Institute of Neuropathology, University Hospital Zurich, for the work:

Tiziana Sonati, Regina M Reimann, Jeppe Falsig, Pravas Kumar Baral, Tracy O’Connor, Simone Hornemann, Sine Yaganoglu, Bei Li, Uli S. Herrmann, Barbara Wieland, Mridula Swayampakula, Muhammad Hafizur Rahman, Dipankar Das, Nat Kav, Roland Riek, Pawel P. Liberski, Michael N.G. James & Adriano Aguzzi. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature, 5 September 2013; 501(7465):102-6.

 

Dr. Paolo Paganetti, NSI/EOC-Laboratorio sperimentale, Bellinzona et Prof. Dr. Maurizio Molinari, Institute for Research in Biomedicine, Bellinzona, for the work:

Paolo Paganetti, Julia Reichwald, Dorothee Bleckmann, Dorothee Abramowski, Domenico Ammaturo, Carmen Barske, Simone Danner, Maurizio Molinari, Matthias Müller, Stéphane Papin, Sabine Rabe, Peter Schmid, Matthias Staufenbiel. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice. Neurobiology of Aging, 2013; 34(12):2866-78.

2010

Dr. Florence Clavaguera, Institut für Pathologie Universitätsspital Basel, for the work:

Clavaguera Florence, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biology : 2009; 11:909-013.

 

PD Dr. méd. Andrea O. Rossetti, Service de neurologie CHUV, Lausanne, for the work:

Rossetti AO, Oddo M, Lagroscino G, Kaplan PW. Prognostication after cardiac arrest hypothermia. A prospective study. Ann Neurol: 2010;67:301-307.

2006

PhD Kilic Ertugrul, Neurologische Klinik Universitätspital Zürich, for the work:

Kilic E, Kilic Ü, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinisotol-3 kinase/Akt pathway mediates VEGEF’s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006 Jun;20(8):1185-7.

Dr. Robert H. Andres, Depatment of Neurosurgery, University Hospital Berne, for the work:

Andres RH, Ducray AD, Huber AW, Pérez-Bouza A, Krebs SH, Schlattner U, Seiler RW, Wallimann T, Widmer HR. Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. Journal of Neurochemistry, Wiley, 2005; 95:33-45.

2003

Dr. Fabienne Picard, Département des Neurosciences HUG, Genève, for the work  :

Picard F, Bertrad D, Le Hellard S, Weiland S, Favre I, Philips H, Bertrand S, Berkovic SF, Malafosse A, Mullery J. How mutations in the nAChRs can cause ADNFLE Epilepsy. Epilepsia, 2002; 43 Suppl 5:112-22.

2002

Dr. Pierre Burkhard, Département des Neurosciences, HUG, Genève, for the work:

Burkhard P, Delavalle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis, Arch Neurology, 2003; 60: 521-528.

 

PD Dr. Hans H Jung, Neurologische Klinik Universitätspital Zürich, for the work:

Jung HH , Hergersberg M, Vogt M, Pahnke J, Treyer V, Röthlisberger B, Kollias SS, Russo D, Frwey BM. McLeod phenotype associated with a XK missense without hematological, neuromuscular or cerebral involvement. Journal of Transfusion.

 

Dr. Alexandre Croquelois, Service de neurologie, CHUV, Lausanne, for the work:

Croquelois A, Wintermark M, Reichert M, Meuli R, Bougousslavsky J. Stroke aphasia, the first 6 hours and after: a perfusion-CT and DWI correlation study. Annals of Neurology.

 

2001

Dr. David Winkler, Department of Neuropathology, Institute of Pathology University of Basel, for the work:

Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloïd angiopathy. J Neuroscience, 1 March 2001; 21(5):1619-1627

 

Copyright © 2020 Fondation Franco Regli. All rights reserved.